Lexpos News

A recorded presentation on what lies ahead for community pharmacy – including Community Pharmacy England’s strategy to improve the outlook for pharmacy owners and their teams – is now available to watch on-demand. Spring 2024 saw two key moments for community pharmacy: the end of the five-year CPCF and a General Election campaign. As critical [...]

The post Community Pharmacy England presents strategy to improve outlook for pharmacy appeared first on Community Pharmacy England.

Community pharmacy owners are being asked to share information and views about increasing Pharmacy First thresholds, as well as the impact of GP action, ahead of the next full Community Pharmacy England Committee meeting in September. Many pharmacies may struggle to meet scheduled increases in the threshold for the monthly Pharmacy First payment and pharmacy [...]

The post Share your opinions on Pharmacy First thresholds: Pharmacy Owner Views Sought appeared first on Community Pharmacy England.

Class 3 Medicines Recall: Trandolapril 0.5mg, 2mg, 4mg Capsules (Accord-UK Ltd) Drug alert number: EL (24)A/35 MDR number: MDR 113-05/24 Date issued: 08 August 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Trandolapril 0.5mg, 2mg, 4mg Capsules (Accord-UK Ltd) Company name: Accord-UK Ltd Product name: Trandolapril 0.5mg [...]

The post MHRA Class 3 Medicines Recall: Trandolapril 0.5mg, 2mg, 4mg Capsules (Accord-UK Ltd) appeared first on Community Pharmacy England.

Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has retrospectively adjusted the reimbursement prices for all strengths of Latuda® (lurasidone) tablets dispensed in April 2024. On 1 April 2024, there was an increase in the NHS list prices of Latuda® (all strengths) manufactured [...]

The post Latuda®(lurasidone) tablets – retrospective reimbursement price adjustment for April 2024 appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England on behalf of community pharmacy contractors, the Department of Health and Social Care (DHSC) has redetermined the reimbursement prices for EpiPen® and Jext® (adrenaline) preparations dispensed in July 2024. On 1 July 2024, there was an increase in the NHS list prices of EpiPen® and Jext® preparations manufactured by [...]

The post EpiPen® and Jext® – reimbursement price changes for July 2024 appeared first on Community Pharmacy England.